Related Experiment Video
Updated: May 21, 2026

07:08
A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
Published on: October 20, 2016
Multiplex array proteomics detects increased MMP-8 in CSF after spinal cord injury
Matthew Light1, Kenneth H Minor, Peter DeWitt
1Department of Neurosurgery, University of Colorado School of Medicine, Building RC-1 North, Room P18-9400, 12800 E 19th Avenue, Aurora, CO 80045, USA.
Journal of Neuroinflammation
|June 13, 2012
Summary
Researchers identified matrix metalloproteinase-8 as a novel subacute spinal cord injury (SCI) biomarker in cerebrospinal fluid (CSF). This multiplex assay offers a high-throughput method for profiling inflammatory changes and assessing SCI severity.
Area of Science:
- Neuroscience
- Immunology
- Biomarker Discovery
Background:
- Studying spinal cord injury (SCI) inflammation is challenging due to limited targets and small cerebrospinal fluid (CSF) sample volumes in rodent models.
- Novel multiplex assays offer potential to overcome limitations of traditional methods for studying inflammatory biomarkers in SCI.
Purpose of the Study:
- To characterize the inflammatory profile in CSF at a subacute time point following traumatic spinal cord injury (SCI) in a rodent model.
- To evaluate a microarray proteomics platform for its application in analyzing CSF biomarkers in SCI.
Main Methods:
- A 34-cytokine sandwich ELISA microarray was employed to analyze CSF samples collected 12 days post-cervical SCI in adult rats.
- Statistical methods including Bonferroni and Benjamini-Hochburg corrections, and a linear mixed model were used for data analysis.
Main Results:
- Matrix metalloproteinase-8 (MMP-8) protein was identified as a novel subacute SCI biomarker with elevated levels detected in CSF.
- The study demonstrated the successful application of statistical models designed for multiplex testing in SCI biomarker analysis.
Conclusions:
- The microarray assay provides a high-throughput, sensitive, and sample-efficient method for comprehensive inflammatory profiling in SCI.
- Identified biomarkers can aid in objectively assessing SCI severity and evaluating therapeutic responses in clinical settings.

